<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Addiction</journal-id><journal-id journal-id-type="iso-abbrev">Addiction</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Addiction (Abingdon, England)</journal-title></journal-title-group><issn pub-type="ppub">0965-2140</issn><issn pub-type="epub">1360-0443</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10838605</article-id><article-id pub-id-type="pmcid-ver">PMC10838605.319</article-id><article-id pub-id-type="pmcaid">10838605</article-id><article-id pub-id-type="pmcaiid">10838605</article-id><article-id pub-id-type="manuscript-id">NIHMS1957653</article-id><article-id pub-id-type="pmid">37816665</article-id><article-id pub-id-type="doi">10.1111/add.16359</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1957653</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1957653</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Drug Overdose Risk with Benzodiazepine Treatment in Young Adults: Comparative Analysis in Privately and Publicly Individuals</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Bushnell</surname><given-names initials="GA">Greta A</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rynn</surname><given-names initials="MA">Moira A</given-names></name><degrees>MD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gerhard</surname><given-names initials="T">Tobias</given-names></name><degrees>BSPharm, PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Keyes</surname><given-names initials="KM">Katherine M</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hasin</surname><given-names initials="DS">Deborah S</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">5</xref><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cerd&#225;</surname><given-names initials="M">Magdalena</given-names></name><degrees>DrPh</degrees><xref rid="A7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nyandege</surname><given-names initials="A">Abner</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Olfson</surname><given-names initials="M">Mark</given-names></name><degrees>MD, MPH</degrees><xref rid="A5" ref-type="aff">5</xref><xref rid="A6" ref-type="aff">6</xref></contrib></contrib-group><aff id="A1"><label>1</label>Center for Pharmacoepidemiology and Treatment Sciences, Rutgers Institute for Health, Health Care Policy and Aging Research, New Brunswick, NJ</aff><aff id="A2"><label>2</label>Department of Biostatistics and Epidemiology, Rutgers University School of Public Health, Piscataway, NJ</aff><aff id="A3"><label>3</label>Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC</aff><aff id="A4"><label>4</label>Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ</aff><aff id="A5"><label>5</label>Columbia University Mailman School of Public Health, New York, NY</aff><aff id="A6"><label>6</label>Columbia University Irving Medical Center, New York, NY</aff><aff id="A7"><label>7</label>Center for Opioid Epidemiology and Policy, Department of Population Health, New York University School of Medicine, New York, NY</aff><author-notes><corresp id="CR1"><bold>Corresponding author</bold>. Greta A. Bushnell, PhD, Assistant Professor, Center for Pharmacoepidemiology and Treatment Sciences, Rutgers Institute for Health, Health Care Policy and Aging Research, 112 Paterson St., Office #353R, New Brunswick, NJ 08901, <email>greta.bushnell@rutgers.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>10</month><year>2023</year></pub-date><volume>119</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">455048</issue-id><fpage>356</fpage><lpage>368</lpage><pub-history><event event-type="nihms-submitted"><date><day>17</day><month>01</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>02</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-01 00:25:38.220"><day>01</day><month>02</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1957653.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background, Aims.</title><p id="P1">Benzodiazepines (BZDs) carry a risk for drug overdose and are prescribed alone or simultaneously with selective-serotonin reuptake inhibitors (SSRIs) for the treatment of anxiety and depression in young adults. We aimed to examine risks of drug overdose following BZD treatment initiation, and simultaneous BZD and SSRI initiation, compared to SSRI treatment alone in young adults with depression or anxiety.</p></sec><sec id="S2"><title>Design, Setting, Participants.</title><p id="P2">The cohort study used administrative databases covering privately (MarketScan, 1/1/2009-12/31/2018) and publicly (Medicaid, 1/1/2015-12/31/2016) insured young adults (18-29 years) in the United States. Those with depression or anxiety diagnoses newly initiating BZD or SSRI treatment (without BZD or SSRI prescriptions in prior year) were included. Simultaneous &#8220;BZD+SSRI&#8221; initiation was defined as starting BZD and SSRI treatment on the same day.</p></sec><sec id="S3"><title>Interventions.</title><p id="P3">Two treatment comparisons were evaluated: a) BZD vs. SSRI and b) simultaneous BZD+SSRI vs. SSRI.</p></sec><sec id="S4"><title>Measurements.</title><p id="P4">Incident medically treated drug overdose events were identified from emergency department and inpatient encounters (ICD poisoning codes) within 6-months of treatment initiation. Crude and propensity-score adjusted cumulative incidence and hazard ratios (HR) were estimated. Sub-analyses evaluated drug overdose intent.</p></sec><sec id="S5"><title>Findings.</title><p id="P5">The cohorts included 604,664 privately insured young adults (BZD=22%, BZD+SSRI=10%, SSRI=68%) and 110,493 publicly insured young adults (BZD=23%, BZD+SSRI=5%, SSRI=72%). Adjusted HRs of drug overdose for BZD vs. SSRI treatment was 1.36 (95%CI:1.23-1.51) in privately and 1.59 (95%CI:1.37-1.83) in publicly insured young adults. The adjusted HRs of drug overdose for BZD+SSRI treatment vs. SSRI treatment were 1.99(95%CI:1.77-2.25) in privately and 1.98(95%CI:1.47-2.68) in publicly insured young adults.</p></sec><sec id="S6"><title>Conclusions.</title><p id="P6">We observed an increased risk of medically treated drug overdose in young adults initiating BZD treatment or simultaneous BZD+SSRI treatment compared to SSRI treatment alone. These associations were observed in publicly and privately insured individuals. Increased risk of overdose with BZD treatment is an important safety consideration for this young population.</p></sec></abstract><kwd-group><kwd>Overdose</kwd><kwd>poisoning</kwd><kwd>benzodiazepine</kwd><kwd>young adult</kwd><kwd>depression</kwd><kwd>anxiety disorder</kwd><kwd>selective serotonin reuptake inhibitor</kwd><kwd>cohort</kwd><kwd>pharmacoepidemiology</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>